Receiver operating characteristic curve (ROC) for SAPS II and SAPS 3.

<p>Receiver operating characteristic curve (ROC) for SAPS II and SAPS 3.</p

Calibration curve based on the Hosmer and Lemeshow goodness-on-fit C test for SAPS II.

<p>Calibration curve based on the Hosmer and Lemeshow goodness-on-fit C test for SAPS II.</p

Calibration curve based on the Hosmer and Lemeshow goodness-on-fit C test for SAPS 3.

<p>Calibration curve based on the Hosmer and Lemeshow goodness-on-fit C test for SAPS 3.</p

Clinical characteristics of the patients.

<p>Clinical characteristics of the patients.</p

Multivariate analysis of variables that influence thromboprophylaxis use in hospitalized cancer patients.

<p>Multivariate analysis of variables that influence thromboprophylaxis use in hospitalized cancer patients.</p

Multivariate analysis of variables that influence mortality.

<p>Multivariate analysis of variables that influence mortality.</p

Univariate analysis of new variables for NIV mortality prediction.

<p>Values are expressed as mean (standard deviation), unless otherwise stated.</p><p>*COPD/hypoxemic ARF/APE/Neuromuscular disease</p><p>^†p of comparison between subgroups was calculated with t-Student and chi square tests</p><p>Univariate analysis of new variables for NIV mortality prediction.</p

Receiver Operating Characteristic curves in the different prognostic models.

<p>(A) SAPS II and SAPS II-CNIV. (B) SAPS 3 and SAPS 3-CNIV.</p

Clinical application of SAPS 3-CNIV: Death probability according to customized scores.

<p>Clinical application of SAPS 3-CNIV: Death probability according to customized scores.</p

Patient characteristics.

<p>Values are expressed as mean (standard deviation), unless otherwise stated.</p><p>SD: Standard deviation; COPD: chronic obstructive pulmonary disease; ICU: Intensive care unit; ImCU: Intermediate care unit; BP: Blood pressure; C-RP: C-reactive protein</p><p>*Immunosuppression as described in SAPS 3: Use of chemotherapy, radiotherapy, immunosuppressive drugs or corticosteroids in the last 6 months</p><p>Patient characteristics.</p